Clinical Trial Results TV
April 14, 2006: Metabolic Shifts in Heart Failure: A New Target for Pharmacotherapy
This video is sponsored by the Duke Clinical Medical Series.

Topics include:
* Metabolic Shifts in Heart Failure: A New Target for Pharmacotherapy
* 56 y/o White Female w/ Diabetes & Symptoms of DOE, PND, and Peripheral Edema
* We Are Witnessing a National Health Crisis
* The Growing Problem of Diabetic Cardiovascular Disease
* Objectives
* Adult Mammalian Heart Exhibits Energy Substrate Flexibility: A Healthy Balance
* The Insulin-resistant and Diabetic Heart Burns Fat at High Rates
* Genetically Modified Mouse Models of the Diabetic Heart
* microPET-R4-Mice
* Mice w/ Cardiac-restricted Overexpression of PPAR Exhibit Diabetic Myocardial Phenotype

Dr. Joe Rogers has indicated that he is a member of the GlaxoSmithKline Speakers Bureau.

The guest, Daniel Kelly, MD, has indicated that he consults for Sankyo, Pfizer,
Bristol-Myers Squibb, and Lilly. He receives honoraria from Lilly.



Metabolic Shifts in Heart Failure: A New Target for Pharmacotherapy

Please select your viewing options:

Windows Media: 56k 100k
RealPlayer: 56k 100k
Number Viewing:
Need a media player? Please choose one of the free downloads below:
Get Windows Media PlayerDownload RealPlayer

Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
09-26-2017 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted